Seven years after an advisory hearing on the subject, the FDA has determined that cranial electrotherapy stimulation (CES) devices will be slotted as class III devices when used for depression. The ...

The "Global Electrotherapy System Market, By Technology, By Therapy, By Application, By End User, Country Wise Market Analysis, Key Company Profiles, Trends and Recent Developments - Forecast to 2030" ...

CU Boulder alum Griffin Hale was listening to music one day while treating his pain with an electrotherapy device. Each pulsating, electric shock seemed to mesh so beautifully with the various rhythms ...

Zynex has been granted FDA clearance for its NexWave electrotherapy device, according to a Zynex news release. NexWave delivers three modalities of stimulation: interferential, neuromuscular ...

Electromedical Technologies (OTC: EMED) outlines key financial restructuring milestones, upcoming product updates, and new strategic partnerships to drive sustainable growth in the pain management ...

The Food and Drug Administration (FDA) has approved a new cranial electrotherapy stimulator (CES) device for the treatment of anxiety, depression, and insomnia. The Cervella Cranial Electrotherapy ...